Insider Transactions in Q1 2026 at Revolution Medicines, Inc. (RVMD)
Insider Transaction List (Q1 2026)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 07
2026
|
Jack Anders Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,000
-8.47%
|
$980,000
$98.0 P/Share
|
|
Jan 07
2026
|
Jack Anders Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+7.81%
|
$420,000
$42.45 P/Share
|
|
Jan 07
2026
|
Margaret A Horn Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
75,000
-12.72%
|
$7,575,000
$101.57 P/Share
|
|
Jan 07
2026
|
Margaret A Horn Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
75,000
+15.46%
|
$2,700,000
$36.13 P/Share
|